These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4047002)

  • 21. Dosimetric characteristics of a new 125I brachytherapy source.
    Gearheart DM; Drogin A; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Oct; 27(10):2278-85. PubMed ID: 11099194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric characteristics of a double wall 125I source for interstitial brachytherapy.
    Nath R; Melillo A
    Med Phys; 1993; 20(5):1475-83. PubMed ID: 8289731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose distribution of 125I sources in different tissues.
    Huang DY; Schell MC; Weaver KA; Ling CC
    Med Phys; 1990; 17(5):826-32. PubMed ID: 2233568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
    Duggan DM
    Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A self-collimating convolution backprojection algorithm for optimizing dose distributions of I-125 prostate implants.
    Siochi RA; Elson HR; Foster AE; Lamba MA
    Med Phys; 1997 Feb; 24(2):241-9. PubMed ID: 9048364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental determination of dosimetric characteristics of Best 125I brachytherapy source.
    Meigooni AS; Gearheart DM; Sowards K
    Med Phys; 2000 Sep; 27(9):2168-73. PubMed ID: 11011747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interstitial volume implants with I-125 seeds.
    Rao GU; Kan PT; Howells R
    Int J Radiat Oncol Biol Phys; 1981 Mar; 7(3):431-8. PubMed ID: 7275723
    [No Abstract]   [Full Text] [Related]  

  • 29. Dose parameters of 125I and 192Ir seed sources.
    Weaver KA; Smith V; Huang D; Barnett C; Schell MC; Ling C
    Med Phys; 1989; 16(4):636-43. PubMed ID: 2770636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source.
    Meigooni AS; Dini SA; Sowards K; Hayes JL; Al-Otoom A
    Med Phys; 2002 Jun; 29(6):939-42. PubMed ID: 12094988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
    Nath R; Meigooni AS; Muench P; Melillo A
    Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermoluminescent dosimetry of the selectseed 125I interstitial brachytherapy seed.
    Anagnostopoulos G; Baltas D; Karaiskos P; Sandilos P; Papagiannis P; Sakelliou L
    Med Phys; 2002 May; 29(5):709-16. PubMed ID: 12033566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved treatment planning for COMS eye plaques.
    Astrahan MA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of seed loading approaches in prostate brachytherapy.
    Butler WM; Merrick GS; Lief JH; Dorsey AT
    Med Phys; 2000 Feb; 27(2):381-92. PubMed ID: 10718143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New 125I dosimetry in prostatic brachytherapy planning.
    Piermattei A
    Rays; 1993; 18(1):58-62. PubMed ID: 8356241
    [No Abstract]   [Full Text] [Related]  

  • 38. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Physical basics and clinical realization of interstitial brachytherapy of the prostate with iodine 125].
    Kaulich TW; Lamprecht U; Paulsen F; Kahmann F; Maurer U; Henkel TO; Loeser W; Bichler KH; Nüsslin F; Bamberg M
    Strahlenther Onkol; 2002 Oct; 178(10):548-55. PubMed ID: 12386786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic study of imaging uncertainties and their impact on 125I prostate brachytherapy dose evaluation.
    Lindsay PE; Van Dyk J; Battista JJ
    Med Phys; 2003 Jul; 30(7):1897-908. PubMed ID: 12906208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.